BE study design question [Design Issues]

posted by CLR – Singapore, 2012-04-18 08:29 (5174 d 04:42 ago) – Posting: # 8438
Views: 2,760

Hi John,

I think an SD study for swallowed dosing will suffice. For example, the FDA's product-specific guidance for montelukast chewable tablets (http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm088707.pdf) states that the tablet should be swallowed whole - this would ensure the standardised delivery of the dose, as opposed to variability introduced during chewing.

Perhaps other more experienced members of this forum will be able to lend more insight

Clare

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
162 visitors (0 registered, 162 guests [including 18 identified bots]).
Forum time: 13:11 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5